RankingsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Stockholders' equity

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥10.4B
P/E ratio
51.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202511,610-3.46%
Mar 31, 202412,026+1.00%
Mar 31, 202311,907+3.71%
Mar 31, 202211,481+0.84%
Mar 31, 202111,386-4.70%
Mar 31, 202011,947-13.18%
Mar 31, 201913,761-2.45%
Mar 31, 201814,107+1.52%
Mar 31, 201713,897-0.42%
Mar 31, 201613,955-1.20%
Mar 31, 201514,124+2.26%
Mar 31, 201413,813

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)